{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "33077836", "DateCompleted": {"Year": "2020", "Month": "10", "Day": "28"}, "DateRevised": {"Year": "2020", "Month": "12", "Day": "18"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "10", "Day": "19"}], "Language": ["eng"], "ELocationID": ["17699", "10.1038/s41598-020-74715-4"], "Journal": {"ISSN": "2045-2322", "JournalIssue": {"Volume": "10", "Issue": "1", "PubDate": {"Year": "2020", "Month": "Oct", "Day": "19"}}, "Title": "Scientific reports", "ISOAbbreviation": "Sci Rep"}, "ArticleTitle": "Molecular docking study of potential phytochemicals and their effects on the complex of SARS-CoV2 spike protein and human ACE2.", "Pagination": {"StartPage": "17699", "MedlinePgn": "17699"}, "Abstract": {"AbstractText": ["Angiotensin converting enzyme 2 (ACE2) (EC:3.4.17.23) is a transmembrane protein which is considered as a receptor for spike protein binding of novel coronavirus (SARS-CoV2). Since no specific medication is available to treat COVID-19, designing of new drug is important and essential. In this regard, in silico method plays an important role, as it is rapid and cost effective compared to the trial and error methods using experimental studies. Natural products are safe and easily available to treat coronavirus affected patients, in the present alarming situation. In this paper five phytochemicals, which belong to flavonoid and anthraquinone subclass, have been selected as small molecules in molecular docking study of spike protein of SARS-CoV2 with its human receptor ACE2 molecule. Their molecular binding sites on spike protein bound structure with its receptor have been analyzed. From this analysis, hesperidin, emodin and chrysin are selected as competent natural products from both Indian and Chinese medicinal plants, to treat COVID-19. Among them, the phytochemical hesperidin can bind with ACE2 protein and bound structure of ACE2 protein and spike protein of SARS-CoV2 noncompetitively. The binding sites of ACE2 protein for spike protein and hesperidin, are located in different parts of ACE2 protein. Ligand spike protein causes conformational change in three-dimensional structure of protein ACE2, which is confirmed by molecular docking and molecular dynamics studies. This compound modulates the binding energy of bound structure of ACE2 and spike protein. This result indicates that due to presence of hesperidin, the bound structure of ACE2 and spike protein fragment becomes unstable. As a result, this natural product can impart antiviral activity in SARS CoV2 infection. The antiviral activity of these five natural compounds are further experimentally validated with QSAR study."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Gurudas College, Calcutta, India."}], "LastName": "Basu", "ForeName": "Anamika", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Computer Science and Engineering Department, Jadavpur University, Calcutta, India. anasua.sarkar@jadavpuruniversity.in."}], "LastName": "Sarkar", "ForeName": "Anasua", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Computer Science and Engineering Department, Jadavpur University, Calcutta, India."}], "LastName": "Maulik", "ForeName": "Ujjwal", "Initials": "U"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Sci Rep", "NlmUniqueID": "101563288", "ISSNLinking": "2045-2322"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anthraquinones"}, {"RegistryNumber": "0", "NameOfSubstance": "Spike Glycoprotein, Coronavirus"}, {"RegistryNumber": "0", "NameOfSubstance": "spike protein, SARS-CoV-2"}, {"RegistryNumber": "EC 3.4.15.1", "NameOfSubstance": "Peptidyl-Dipeptidase A"}, {"RegistryNumber": "EC 3.4.17.23", "NameOfSubstance": "ACE2 protein, human"}, {"RegistryNumber": "EC 3.4.17.23", "NameOfSubstance": "Angiotensin-Converting Enzyme 2"}, {"RegistryNumber": "KA46RNI6HN", "NameOfSubstance": "Emodin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Allosteric Regulation"}, {"QualifierName": [], "DescriptorName": "Amino Acid Sequence"}, {"QualifierName": [], "DescriptorName": "Angiotensin-Converting Enzyme 2"}, {"QualifierName": ["chemistry", "metabolism"], "DescriptorName": "Anthraquinones"}, {"QualifierName": ["isolation & purification", "metabolism"], "DescriptorName": "Betacoronavirus"}, {"QualifierName": [], "DescriptorName": "Binding Sites"}, {"QualifierName": [], "DescriptorName": "COVID-19"}, {"QualifierName": ["pathology", "virology"], "DescriptorName": "Coronavirus Infections"}, {"QualifierName": ["chemistry", "metabolism"], "DescriptorName": "Emodin"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Pandemics"}, {"QualifierName": ["chemistry", "metabolism"], "DescriptorName": "Peptidyl-Dipeptidase A"}, {"QualifierName": ["pathology", "virology"], "DescriptorName": "Pneumonia, Viral"}, {"QualifierName": [], "DescriptorName": "Protein Binding"}, {"QualifierName": [], "DescriptorName": "Protein Structure, Secondary"}, {"QualifierName": [], "DescriptorName": "Protein Structure, Tertiary"}, {"QualifierName": [], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": ["chemistry", "metabolism"], "DescriptorName": "Spike Glycoprotein, Coronavirus"}], "CoiStatement": "The authors declare no competing interests."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Wrapp D, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367(6483):1260\u20131263. doi: 10.1126/science.abb2507.", "ArticleIdList": ["10.1126/science.abb2507", "PMC7164637", "32075877"]}, {"Citation": "Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020;181(2):281\u2013292.e6. doi: 10.1016/j.cell.2020.02.058.", "ArticleIdList": ["10.1016/j.cell.2020.02.058", "PMC7102599", "32155444"]}, {"Citation": "Tai W, He L, Zhang X, et al. Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: Implication for development of RBD protein as a viral attachment inhibitor and vaccine. Cell. Mol. Immunol. 2020 doi: 10.1038/s41423-020-0400-4.", "ArticleIdList": ["10.1038/s41423-020-0400-4", "PMC7091888", "32203189"]}, {"Citation": "Du L, He Y, Zhou Y, Liu S, Zheng BJ, Jiang S. The spike protein of SARS-CoV-a target for vaccine and therapeutic development. Nat. Rev. Microbiol. 2009;7:226\u2013236. doi: 10.1038/nrmicro2090.", "ArticleIdList": ["10.1038/nrmicro2090", "PMC2750777", "19198616"]}, {"Citation": "Li W, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426:450\u2013454. doi: 10.1038/nature02145.", "ArticleIdList": ["10.1038/nature02145", "PMC7095016", "14647384"]}, {"Citation": "Xu X, et al. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its Spike protein for risk of human transmission. Sci. China Life Sci. 2020 doi: 10.1007/s11427-020-1637-5.", "ArticleIdList": ["10.1007/s11427-020-1637-5", "PMC7089049", "32009228"]}, {"Citation": "Li W, et al. Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2. EMBO J. 2005;24(8):1634\u20131643. doi: 10.1038/sj.emboj.7600640.", "ArticleIdList": ["10.1038/sj.emboj.7600640", "PMC1142572", "15791205"]}, {"Citation": "Zhou P, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020 doi: 10.1038/s41586-020-2012-7.", "ArticleIdList": ["10.1038/s41586-020-2012-7", "PMC7095418", "32015507"]}, {"Citation": "Zhang H, et al. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: Molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020;46:586\u2013590. doi: 10.1007/s00134-020-05985-9.", "ArticleIdList": ["10.1007/s00134-020-05985-9", "PMC7079879", "32125455"]}, {"Citation": "Kozma D, Simon I, Tusnady GE. PDBTM: Protein Data Bank of transmembrane proteins after 8 years. Nucleic Acids Res. 2012;41(D1):D524\u2013D529. doi: 10.1093/nar/gks1169.", "ArticleIdList": ["10.1093/nar/gks1169", "PMC3531219", "23203988"]}, {"Citation": "Yin X, Yang J, Xiao F, Yang Y, Shen HB. MemBrain: An easy-to-use online webserver for transmembrane protein structure prediction. Nano-Micro Lett. 2018;10(1):2. doi: 10.1007/s40820-017-0156-2.", "ArticleIdList": ["10.1007/s40820-017-0156-2", "PMC6199043", "30393651"]}, {"Citation": "Varshney, K. K., Varshney, M., & Nath, B. Molecular Modeling of Isolated Phytochemicals from Ocimum Sanctum Towards Exploring Potential Inhibitors of SARS Coronavirus Main Protease and Papain-Like Protease to Treat COVID-19. https://ssrn.com/abstract=3554371. Accessed Mar 14 2020."}, {"Citation": "Muhammad, T. Q. Safar, M. A., Mubarak, A. A., & Ling-Ling, C. Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants. J. Pharm. Anal.10.1016/j.jpha.2020.03.009. (2020) https://www.sciencedirect.com/science/article/pii/S2095177920301271(ISSN 2095-1779).", "ArticleIdList": ["PMC7156227", "32296570"]}, {"Citation": "Utomo, R. Y., Ikawati, M., & Meiyanto, E. Revealing the potency of citrus and galangal constituents to halt SARS-CoV-2 infection. Preprints 2020, 2020030214. 10.20944/preprints202003.0214.v1."}, {"Citation": "Gupta MK, Vemula S, Donde R, Gouda G, Behera L, Vadde R. In-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel. J. Biomol. Struct. Dyn. 2020 doi: 10.1080/07391102.2020.1751300.", "ArticleIdList": ["10.1080/07391102.2020.1751300", "PMC7171389", "32238078"]}, {"Citation": "Canrong W, et al. Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharm. Sin. B. 2020;10(5):766\u2013788. doi: 10.1016/j.apsb.2020.02.008.", "ArticleIdList": ["10.1016/j.apsb.2020.02.008", "PMC7102550", "32292689"]}, {"Citation": "https://www.ncbi.nlm.nih.gov/."}, {"Citation": "Ho TY, Wu SL, Chen JC, Li CC, Hsiang CY. Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction. Antiviral Res. 2007;74(2):92\u2013101. doi: 10.1016/j.antiviral.2006.04.014.", "ArticleIdList": ["10.1016/j.antiviral.2006.04.014", "PMC7114332", "16730806"]}, {"Citation": "Mohanraj K, et al. IMPPAT: Acurated database of Indian Medicinal Plants, Phytochemistry and Therapeutics. Scie. Rep. 2018;8(1):1\u201317. doi: 10.1038/s41598-017-17765-5.", "ArticleIdList": ["10.1038/s41598-017-17765-5", "PMC5847565", "29531263"]}, {"Citation": "Laskowski RA. PDBsum new things. Nucleic Acids Res. 2009;37((suppl_1)):D355\u2013D359. doi: 10.1093/nar/gkn860.", "ArticleIdList": ["10.1093/nar/gkn860", "PMC2686501", "18996896"]}, {"Citation": "Schwede T, Kopp J, Guex N, Peitsch MC. SWISS-MODEL: An automated protein homology-modeling server. Nucleic Acids Res. 2003;31(13):3381\u20133385. doi: 10.1093/nar/gkg520.", "ArticleIdList": ["10.1093/nar/gkg520", "PMC168927", "12824332"]}, {"Citation": "Camacho C, Coulouris G, Avagyan V, Ma N, Papadopoulos J, Bealer K, Madden TL. BLAST+: Architecture and applications. BMC Bioinform. 2009;10:421\u2013430. doi: 10.1186/1471-2105-10-421.", "ArticleIdList": ["10.1186/1471-2105-10-421", "PMC2803857", "20003500"]}, {"Citation": "Remmert M, Biegert A, Hauser A, S\u00f6ding J. HHblits: Lightning-fast iterative protein sequence searching by HMM-HMM alignment. Nat. Methods. 2012;9:173\u2013175. doi: 10.1038/nmeth.1818.", "ArticleIdList": ["10.1038/nmeth.1818", "22198341"]}, {"Citation": "Williams CJ, et al. MolProbity: More and better reference data for improved all-atom structure validation. Protein Sci. 2018;27(1):293\u2013315. doi: 10.1002/pro.3330.", "ArticleIdList": ["10.1002/pro.3330", "PMC5734394", "29067766"]}, {"Citation": "Lovell SC, et al. Structure validation by Calpha geometry: Phi, psi and Cbeta deviation. Prot. Struct. Funct. Genet. 2002;50:437\u2013450. doi: 10.1002/prot.10286.", "ArticleIdList": ["10.1002/prot.10286", "12557186"]}, {"Citation": "Towler P, et al. ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis. J. Biol. Chem. 2004;279(17):17996\u201318007. doi: 10.1074/jbc.M311191200.", "ArticleIdList": ["10.1074/jbc.M311191200", "PMC7980034", "14754895"]}, {"Citation": "Kozakov D, Hall DR, Xia B, Porter KA, Padhorny D, Yueh C, Beglov D, Vajda S. The ClusPro web server for protein\u2013protein docking. Nat. Protoc. 2017;12(2):255\u2013278. doi: 10.1038/nprot.2016.169.", "ArticleIdList": ["10.1038/nprot.2016.169", "PMC5540229", "28079879"]}, {"Citation": "Zargar BA, Masoodi MH, Ahmed B, Ganie SA. Phytoconstituents and therapeutic uses of Rheum emodi wall. ex Meissn. Food Chem. 2011;128(3):585\u2013589. doi: 10.1016/j.foodchem.2011.03.083.", "ArticleIdList": ["10.1016/j.foodchem.2011.03.083"]}, {"Citation": "Izhaki I. Emodin\u2014a secondary metabolite with multiple ecological functions in higher plants. New Phytol. 2002;155(2):205\u2013217. doi: 10.1046/j.1469-8137.2002.00459.x.", "ArticleIdList": ["10.1046/j.1469-8137.2002.00459.x"]}, {"Citation": "Betts MJ, Russell RB. Amino acid properties and consequences of substitutions. Bioinform. Genet. 2003;317:289. doi: 10.1002/0470867302.ch14.", "ArticleIdList": ["10.1002/0470867302.ch14"]}, {"Citation": "Rakesh, S., Chapter 59\u2014polyphenols in health and disease: Practice and mechanisms of benefits. In Polyphenols in Human Health and Disease (eds. Ronald, R. W., Victor, R. P., Sherma, Z.), 757\u2013778 (Academic Press, 2014). 10.1016/B978-0-12-398456-2.00059-1. https://www.sciencedirect.com/science/article/pii/B9780123984562000591. (ISBN 9780123984562)"}, {"Citation": "Anand, A. Zanwar, Sachin L. Badole, Pankaj S. Shende, Mahabaleshwar V. Hegde, Subhash L. Bodhankar, Chapter 76\u2014cardiovascular effects of hesperidin: A flavanone glycoside. In Polyphenols in Human Health and Disease (eds. Ronald R. W., Victor R. P., Sherma Z.,) 989\u2013992 (Academic Press, 2014). ISBN 9780123984562. 10.1016/B978-0-12-398456-2.00076-1. https://www.sciencedirect.com/science/article/pii/B9780123984562000761."}, {"Citation": "Dai JP, et al. Emodin inhibition of influenza A virus replication and influenza viral pneumonia via the Nrf2, TLR4, p38/JNK and NF-kappaB pathways. Molecules. 2017;22(10):1754. doi: 10.3390/molecules22101754.", "ArticleIdList": ["10.3390/molecules22101754", "PMC6151665", "29057806"]}, {"Citation": "Wang J, Zhang T, Du J, Cui S, Yang F, Jin Q. Anti-enterovirus 71 effects of chrysin and its phosphate ester. PLoS\u00a0One. 2014;9:3.", "ArticleIdList": ["PMC3943725", "24598537"]}, {"Citation": "Song JH, et al. Antiviral activity of chrysin derivatives against coxsackievirus B3 in vitro and in vivo. Biomol. Therap. 2015;23(5):465. doi: 10.4062/biomolther.2015.095.", "ArticleIdList": ["10.4062/biomolther.2015.095", "PMC4556207", "26336587"]}, {"Citation": "Guex N, Peitsch MC, Schwede T. Automated comparative protein structure modeling with SWISS-MODEL and Swiss-PdbViewer: A historical perspective. Electrophoresis. 2009;30:S162\u2013S173. doi: 10.1002/elps.200900140.", "ArticleIdList": ["10.1002/elps.200900140", "19517507"]}, {"Citation": "Studer G, Rempfer C, Waterhouse AM, Gumienny G, Haas J, Schwede T. QMEANDisCo\u2014distance constraints applied on model quality estimation. Bioinformatics. 2020;36:1765\u20131771. doi: 10.1093/bioinformatics/btz828.", "ArticleIdList": ["10.1093/bioinformatics/btz828", "PMC7075525", "31697312"]}, {"Citation": "Laskowski RA, MacArthur MW, Thornton JM. PROCHECK: Validation of protein structure coordinates, in International Tables of Crystallography, Volume F. In: Rossmann MG, Arnold ED, editors. Crystallography of Biological Macromolecules. The Netherlands: Kluwer Academic Publishers; 2001. pp. 722\u2013725."}, {"Citation": "Chen VB, et al. MolProbity: All-atom structure validation for macromolecular crystallography. Acta Crystallogr. D Biol. Crystallogr. 2010;66(1):12\u201321. doi: 10.1107/S0907444909042073.", "ArticleIdList": ["10.1107/S0907444909042073", "PMC2803126", "20057044"]}, {"Citation": "Kozakov D, et al. How good is automated protein docking? Prot. Struct. Funct. Bioinf. 2013;81(12):2159\u20132166. doi: 10.1002/prot.24403.", "ArticleIdList": ["10.1002/prot.24403", "PMC3934018", "23996272"]}, {"Citation": "Grosdidier A, Zoete V, Michielin O. SwissDock, a protein-small molecule docking web service based on EADock DSS. Nucleic Acids Res. 2011;39(suppl_2):W270\u2013W277. doi: 10.1093/nar/gkr366.", "ArticleIdList": ["10.1093/nar/gkr366", "PMC3125772", "21624888"]}, {"Citation": "Grosdidier A, Zoete V, Michielin O. Fast docking using the CHARMM force field with EADock DSS. J. Comput. Chem. 2011;32(10):2149\u20132159. doi: 10.1002/jcc.21797.", "ArticleIdList": ["10.1002/jcc.21797", "21541955"]}, {"Citation": "Zoete V, Grosdidier A, Cuendet M, Michielin O. Use of the FACTS solvation model for protein\u2013ligand docking calculations. Application to EADock. J. Mol. Recogn. 2010;23(5):457\u2013461. doi: 10.1002/jmr.1012.", "ArticleIdList": ["10.1002/jmr.1012", "20101644"]}, {"Citation": "Pettersen EF, et al. UCSF Chimera\u2014a visualization system for exploratory research and analysis. J. Comput. Chem. 2004;25(13):1605\u20131612. doi: 10.1002/jcc.20084.", "ArticleIdList": ["10.1002/jcc.20084", "15264254"]}, {"Citation": "https://www.cgl.ucsf.edu/chimera/."}, {"Citation": "Vangone A, Bonvin AMJJ. Contact-based prediction of binding affinity in protein\u2013protein complexes. eLife. 2015;4:e07454. doi: 10.7554/eLife.07454.", "ArticleIdList": ["10.7554/eLife.07454", "PMC4523921", "26193119"]}, {"Citation": "Xue L, Rodrigues J, Kastritis P, Bonvin AMJJ, Vangone A. PRODIGY: A web-server for predicting the binding affinity in protein-protein complexes. Bioinformatics. 2016 doi: 10.1093/bioinformatics/btw514.", "ArticleIdList": ["10.1093/bioinformatics/btw514", "27503228"]}, {"Citation": "dos Santos KB, Guedes IA, Karl ALM, Dardenne L. Highly flexible ligand docking: Benchmarking of the DockThor program on the LEADS-PEP protein\u2013peptide dataset. J. Chem. Inf. Model. 2020 doi: 10.1021/acs.jcim.9b00905.", "ArticleIdList": ["10.1021/acs.jcim.9b00905", "31922754"]}]}], "History": [{"Year": "2020", "Month": "4", "Day": "22"}, {"Year": "2020", "Month": "10", "Day": "6"}, {"Year": "2020", "Month": "10", "Day": "20", "Hour": "6", "Minute": "20"}, {"Year": "2020", "Month": "10", "Day": "21", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "10", "Day": "29", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "10", "Day": "19"}], "PublicationStatus": "epublish", "ArticleIdList": ["33077836", "PMC7573581", "10.1038/s41598-020-74715-4", "10.1038/s41598-020-74715-4"]}}]}